A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis

Clinical trial NCT04057937 · COMPLETED

Trial details

NCT number: NCT04057937
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Palmoplantaris Pustulosis

Start date: 2019-10-16
Primary completion: 2021-01-18
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.